BIOMAT Database Logo BIOMAT Database Logo

Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup. 1995

A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Department of Microbiology, National Institute of Cholera and Enteric Diseases, Beliaghata, Calcutta, India.

Sixty-nine strains of Vibrio cholerae O1 isolated at different times were analysed to investigate if there were any differences among the O1 strains isolated before, during and after the advent of the O139 serogroup. Of the 69 O1 strains examined, 68 belonged to the Ogawa serotype while one belonged to the Inaba serotype. With the exception of one strain all other strains of V. cholerae O1 belonged to the eltor biotype. A single O1 strain isolated before the emergence of the O139 serogroup could not be classified as either eltor or classical biotype because it was resistant to both classical and eltor specific bacteriophages. Marked variations in the susceptibility to antibiotics of V. cholerae O1 isolated during the different periods were observed. In addition, strains of V. cholerae isolated after the epidemic of serogroup O139 in Calcutta showed an expanding R-type with resistance to a variety of drugs as compared to the O1 strains isolated before the advent of the O139 serogroup. From this study, it is clear that there is a substantial mobility in genetic elements of V. cholerae O1 which necessitates a continuous monitoring to keep abreast of the changing traits of the etiologic agent of cholera.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002771 Cholera An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated. Vibrio cholerae Infection,Choleras,Infection, Vibrio cholerae,Infections, Vibrio cholerae,Vibrio cholerae Infections
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Biotype-specific probe for Vibrio cholerae serogroup O1.
April 1990, Journal of clinical microbiology,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Phenotypic and molecular characterization of Vibrio cholerae O1 isolated in Samutsakorn, Thailand before, during and after the emergence of V. cholerae O139.
October 1998, Epidemiology and infection,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh.
March 1997, Journal of clinical microbiology,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Vibrio cholerae O139 El Tor biotype.
March 1994, Lancet (London, England),
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Re-emergence of Vibrio cholerae O139 serogroup during 1998 in Nagpur (Maharashtra), India.
January 1999, The Indian journal of medical research,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.
April 1996, Journal of clinical microbiology,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
September 2002, The Indian journal of medical research,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
[Vibrio cholerae serogroups O1 and O139: susceptibility to antibiotics during 7th cholera pandemic].
January 2008, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
[ISOLATION OF ANTIBIOTICS RESISTANCE GENES IN VIBRIO CHOLERAE O1 AND O139 SEROGROUP STRAINS].
January 2015, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A K Mukhopadhyay, and S Garg, and G B Nair, and S Kar, and R K Ghosh, and S Pajni, and A Ghosh, and T Shimada, and T Takeda, and Y Takeda
Emergence of Vibrio cholerae O1 classical biotype in 2012 in Iran.
February 2014, Letters in applied microbiology,
Copied contents to your clipboard!